Moderna, inc. (MRNA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
Revenue:
Total revenue

52,573

60,209

81,575

106,286

122,054

135,068

0

0

0

Operating expenses:
Research and development

481,033

496,309

529,053

518,388

494,371

454,082

0

0

0

General and administrative

106,481

109,620

121,987

112,324

105,188

94,252

0

0

0

Total operating expenses

587,514

605,929

651,040

630,712

599,559

548,334

0

0

0

Loss from operations

-534,941

-545,720

-569,465

-524,426

-477,505

-413,266

0

0

0

Interest income

35,410

38,530

39,440

36,707

32,786

27,023

0

0

0

Other expense, net

-6,749

-7,526

-2,583

-1,848

87

1,835

0

0

0

Loss before income taxes

-506,280

-514,716

-532,608

-489,567

-444,632

-384,408

0

0

0

Provision for (benefit from) income taxes

-605

-695

-358

-180

302

326

0

0

0

Net Income (Loss) Attributable to Parent

-505,654

-514,000

-532,216

-489,353

-444,900

-384,700

0

0

0

Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Net loss attributable to common stockholders

-

-

-535,004

-499,629

-

-401,857

0

0

0

Net loss per share, basic and diluted (usd per share)

-0.35

-0.37

-0.37

-0.41

-0.40

-1.04

-1.32

-1.43

-1.16

Weighted average common shares used in net loss per share, basic and diluted (in shares)

353,105

334,453

330,769

329,176

328,809

126,803

66,283

65,938

65,430

Collaboration revenue
Total revenue

32,689

42,803

52,489

59,810

69,710

76,519

0

0

0

Collaboration revenue from related party
Total revenue

0

-

-

-

0

-

-

-

-

Revenues

-

-

17,553

33,556

-

-

0

0

0

Grant revenue
Total revenue

14,195

12,173

11,533

12,920

12,887

12,556

0

0

0